Kezar Life Sciences, Inc. (KZR) Social Stream
KEZAR LIFE SCIENCES INC (KZR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KZR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 4 | $15 | $12 | $13.5 | $0.906 | 1390.07% |
| 2021-11-16 | 5 | $20 | $15 | $17.5 | $0.906 | 1831.57% |
| 2021-12-08 | 5 | $20 | $15 | $18 | $0.906 | 1886.75% |
| 2022-03-18 | 5 | $27 | $19 | $22.666 | $0.906 | 2401.77% |
| 2022-05-04 | 5 | $22 | $14 | $19 | $0.906 | 1997.13% |
| 2022-06-28 | 5 | $22 | $14 | $18.666 | $0.906 | 1960.26% |
| 2023-01-03 | 5 | $21 | $14 | $17.333 | $0.906 | 1813.13% |
| 2023-03-16 | 5 | $21 | $14 | $16.666 | $0.906 | 1739.51% |
| 2023-05-11 | 5 | $21 | $14 | $16.666 | $0.906 | 1739.51% |
| 2023-05-12 | 5 | $19 | $13 | $15.666 | $0.906 | 1629.14% |
| 2023-08-10 | 5 | $19 | $13 | $15.666 | $0.906 | 1629.14% |
| 2023-08-11 | 5 | $18 | $4 | $12.333 | $0.906 | 1261.26% |
| 2023-10-12 | 5 | $20 | $4 | $13 | $0.906 | 1334.88% |
| 2023-11-14 | 5 | $20 | $2 | $11.666 | $0.906 | 1187.64% |
The Trend in the Analyst Price Target
Over the past 24 months, KZR's average price target has gone down $1.83.
KZR reports an average of 781.85% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-16 | 5 | 21 | 14 | 16.666 | 3.820 | 336.28% |
| 2023-05-12 | 5 | 19 | 14 | 16.000 | 2.620 | 510.69% |
| 2023-08-10 | 5 | 19 | 13 | 15.666 | 2.050 | 664.2% |
| 2023-08-11 | 5 | 18 | 4 | 12.333 | 1.510 | 716.75% |
| 2023-10-12 | 5 | 20 | 4 | 13.000 | 0.916 | 1319.21% |
KZR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
KZR's average broker recommendation rating worsened by 0.8 over the prior 20 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KZR as an investment opportunity.
- In the context of all US stocks, KEZAR LIFE SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1476.62% of them.
- To contextualize these metrics, consider that out of all US stocks, KEZAR LIFE SCIENCES INC's number of analysts covering the stock is greater than 283.11% of them.
- KZR has a lower variance in analysts' estimates than -388.58% of Pharmaceutical Products stocks.
- KZR has a higher average analyst price target than 434.52% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEZAR LIFE SCIENCES INC are XERS, VRCA, and ITRM.
View All Top Stocks by Price Target
Is KZR a Buy, Hold or Sell? See the POWR Ratings now!